Illumina PT Raised to $72.00 at Cantor Fitzgerald (ILMN)
Research analysts at Cantor Fitzgerald boosted their price target on shares of Illumina (NASDAQ:ILMN) from $63.00 to $72.00 in a report released on Wednesday, StockRatingsNetwork.com reports. The firm currently has a “hold” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential downside of 22.82% from the stock’s previous close.
In other Illumina news, SVP Nicholas Naclerio sold 20,000 shares of the stock on the open market in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $90.00, for a total transaction of $1,800,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
A number of other analysts have also recently weighed in on ILMN. Analysts at ISI Group raised their price target on shares of Illumina to $85.00 in a research note to investors on Tuesday, October 22nd. They now have a “neutral” rating on the stock. Separately, analysts at Barclays raised their price target on shares of Illumina from $85.00 to $90.00 in a research note to investors on Tuesday, October 22nd. They now have an “overweight” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Illumina from $84.00 to $95.00 in a research note to investors on Tuesday, October 22nd. They now have an “outperform” rating on the stock. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Illumina presently has a consensus rating of “Buy” and a consensus price target of $80.79.
Illumina (NASDAQ:ILMN) opened at 93.29 on Wednesday. Illumina has a 1-year low of $44.78 and a 1-year high of $84.85. The stock’s 50-day moving average is $79.25 and its 200-day moving average is $68.21. The company has a market cap of $11.672 billion and a P/E ratio of 109.19.
Illumina (NASDAQ:ILMN) last released its earnings data on Monday, October 21st. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.77 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.